Providing Scholarships, Class Reunion Assistance, and More...


The recently developed DNA-guided statin diagnostic assessments are created to identify folks who are genetically vunerable to muscle discomfort while on these statins and who may develop muscular damage while on high dosage statin therapy. Gualberto Ruano, M.D., Ph.D. Paul D. Thompson, M.D., Chief of Cardiology at the Henry Low Cardiovascular Middle of Hartford Medical center commented: Growing proof indicates that genetics determines who develops muscles issues with statins. The partnership allows us to go after the ultimate implementation research of the multi-gene biomarker program to personalize cardiovascular therapy. .. AutoGenomics, Genomas sign contract to build up DNA-guided diagnostic systems AutoGenomics, Inc, a head in automated microarray technology for molecular diagnostics, and Genomas, a biomedical business enabling DNA-guided medication for personal health care, announced today they have signed an contract to jointly develop genetic lab tests and DNA-guided diagnostic systems for optimal collection of statins and for improved delivery of statin therapy for the treating cardiovascular disease, diabetes and obesity.Due to its long history of use, the side effects and safety characteristics of minocycline are popular. More research will be needed to regulate how minocycline exerts its beneficial effects in FXS, and to clarify the most effective dose and amount of treatment. ‘Further studies including long term follow up on people treated with minocycline are warranted with a careful assessment of side effects and benefits,’ Dr Leigh and colleagues conclude.

CTI BioPharma’s pacritinib granted FDA Fast Track designation for treatment of myelofibrosis CTI BioPharma Corp.